Hypersensitivity Reaction After Administration of Crotalidae Polyvalent Immune Fab (CroFab)

Lena Truong, Takla R Anis, Layla Najibfard, Edwin Peck Pharmacy Department, Henry Mayo Newhall Hospital, Valencia, CA, USA, Emergency Department, Henry Mayo Newhall Hospital, Valencia, CA, USACorrespondence: Lena Truong, Email Truongl@henrymayo.com Takla R Anis, Email Takla.anis@gmail.comAbstract: C...

Full description

Saved in:
Bibliographic Details
Main Authors: Truong L, Anis TR, Najibfard L, Peck E
Format: Article
Language:English
Published: Dove Medical Press 2025-03-01
Series:Clinical Pharmacology: Advances and Applications
Subjects:
Online Access:https://www.dovepress.com/hypersensitivity-reaction-after-administration-of-crotalidae-polyvalen-peer-reviewed-fulltext-article-CPAA
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850253609210478592
author Truong L
Anis TR
Najibfard L
Peck E
author_facet Truong L
Anis TR
Najibfard L
Peck E
author_sort Truong L
collection DOAJ
description Lena Truong, Takla R Anis, Layla Najibfard, Edwin Peck Pharmacy Department, Henry Mayo Newhall Hospital, Valencia, CA, USA, Emergency Department, Henry Mayo Newhall Hospital, Valencia, CA, USACorrespondence: Lena Truong, Email Truongl@henrymayo.com Takla R Anis, Email Takla.anis@gmail.comAbstract: Crotalidae polyvalent immune Fab (CroFab) is an antivenin that is FDA approved and commonly used to treat envenomations caused by North American pit vipers. Although CroFab has been widely used since the early 2000s, hypersensitivity reactions like type I, type IV, and angioedema have been reported in the literature. We present a case of CroFab induced hypersensitivity reaction in a 41-year-old male shortly after starting CroFab infusion. Furthermore, this patient developed anaphylaxis symptoms including: difficulty breathing, oropharyngeal edema, dysphagia, wheezing, and chest tightness. This was resolved upon stopping CroFab infusion and administering epinephrine, methylprednisolone, diphenhydramine, and famotidine. The reaction occurred again when CroFab was re-introduced despite infusing it at a much slower rate. Interestingly, this patient successfully tolerated crotalidae immune F(abʹ)2 (equine) antivenom (ANAVIP) upon switching him from CroFab. Hypersensitivity reactions to CroFab can be life-threatening and warrant immediate attention and treatment in a multidisciplinary setting.Keywords: CroFab, ANAVIP, hypersensitivity reactions, anaphylaxis, snake bites
format Article
id doaj-art-1a2983fcdfde41c5a07f82a309a146f3
institution OA Journals
issn 1179-1438
language English
publishDate 2025-03-01
publisher Dove Medical Press
record_format Article
series Clinical Pharmacology: Advances and Applications
spelling doaj-art-1a2983fcdfde41c5a07f82a309a146f32025-08-20T01:57:20ZengDove Medical PressClinical Pharmacology: Advances and Applications1179-14382025-03-01Volume 172528100972Hypersensitivity Reaction After Administration of Crotalidae Polyvalent Immune Fab (CroFab)Truong LAnis TRNajibfard LPeck ELena Truong, Takla R Anis, Layla Najibfard, Edwin Peck Pharmacy Department, Henry Mayo Newhall Hospital, Valencia, CA, USA, Emergency Department, Henry Mayo Newhall Hospital, Valencia, CA, USACorrespondence: Lena Truong, Email Truongl@henrymayo.com Takla R Anis, Email Takla.anis@gmail.comAbstract: Crotalidae polyvalent immune Fab (CroFab) is an antivenin that is FDA approved and commonly used to treat envenomations caused by North American pit vipers. Although CroFab has been widely used since the early 2000s, hypersensitivity reactions like type I, type IV, and angioedema have been reported in the literature. We present a case of CroFab induced hypersensitivity reaction in a 41-year-old male shortly after starting CroFab infusion. Furthermore, this patient developed anaphylaxis symptoms including: difficulty breathing, oropharyngeal edema, dysphagia, wheezing, and chest tightness. This was resolved upon stopping CroFab infusion and administering epinephrine, methylprednisolone, diphenhydramine, and famotidine. The reaction occurred again when CroFab was re-introduced despite infusing it at a much slower rate. Interestingly, this patient successfully tolerated crotalidae immune F(abʹ)2 (equine) antivenom (ANAVIP) upon switching him from CroFab. Hypersensitivity reactions to CroFab can be life-threatening and warrant immediate attention and treatment in a multidisciplinary setting.Keywords: CroFab, ANAVIP, hypersensitivity reactions, anaphylaxis, snake biteshttps://www.dovepress.com/hypersensitivity-reaction-after-administration-of-crotalidae-polyvalen-peer-reviewed-fulltext-article-CPAAcrofabanaviphypersensitivity reactionsanaphylaxissnake bites.
spellingShingle Truong L
Anis TR
Najibfard L
Peck E
Hypersensitivity Reaction After Administration of Crotalidae Polyvalent Immune Fab (CroFab)
Clinical Pharmacology: Advances and Applications
crofab
anavip
hypersensitivity reactions
anaphylaxis
snake bites.
title Hypersensitivity Reaction After Administration of Crotalidae Polyvalent Immune Fab (CroFab)
title_full Hypersensitivity Reaction After Administration of Crotalidae Polyvalent Immune Fab (CroFab)
title_fullStr Hypersensitivity Reaction After Administration of Crotalidae Polyvalent Immune Fab (CroFab)
title_full_unstemmed Hypersensitivity Reaction After Administration of Crotalidae Polyvalent Immune Fab (CroFab)
title_short Hypersensitivity Reaction After Administration of Crotalidae Polyvalent Immune Fab (CroFab)
title_sort hypersensitivity reaction after administration of crotalidae polyvalent immune fab crofab
topic crofab
anavip
hypersensitivity reactions
anaphylaxis
snake bites.
url https://www.dovepress.com/hypersensitivity-reaction-after-administration-of-crotalidae-polyvalen-peer-reviewed-fulltext-article-CPAA
work_keys_str_mv AT truongl hypersensitivityreactionafteradministrationofcrotalidaepolyvalentimmunefabcrofab
AT anistr hypersensitivityreactionafteradministrationofcrotalidaepolyvalentimmunefabcrofab
AT najibfardl hypersensitivityreactionafteradministrationofcrotalidaepolyvalentimmunefabcrofab
AT pecke hypersensitivityreactionafteradministrationofcrotalidaepolyvalentimmunefabcrofab